header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-8506
Fish name: rpl11hi3820bTg/hi3820bTg
Genotype: rpl11hi3820bTg/hi3820bTg
Targeting Reagent: none
HUMAN DISEASE MODELED by rpl11hi3820bTg/hi3820bTg
Human Disease Conditions Citations
Diamond-Blackfan anemia standard conditions (3)
GENE EXPRESSION
Gene expression in rpl11hi3820bTg/hi3820bTg
RNA expression
Expressed Gene Structure Conditions Figures
baxa standard conditions Fig. 3 from Danilova et al., 2011
bbc3 standard conditions Fig. 3Fig. 6 from Danilova et al., 2011
chemical treatment: drug Fig. 6 from Danilova et al., 2011
bop1 standard conditions Fig. 3 from Chakraborty et al., 2017
brf1a standard conditions Fig. 5 from Danilova et al., 2011
c6 standard conditions Fig. 5 from Danilova et al., 2018
ccng1 standard conditions Fig. 3 from Danilova et al., 2011
cdkn1a standard conditions Fig. 3Fig. 6 from Danilova et al., 2011
chemical treatment: drug Fig. 6 from Danilova et al., 2011
cfb standard conditions Fig. 5 from Danilova et al., 2018
efnb2a standard conditions Fig. 2 from Danilova et al., 2011
fosab standard conditions Fig. 5 from Danilova et al., 2011
gnl3 standard conditions Fig. 3 from Chakraborty et al., 2017
ifih1 standard conditions Fig. 2 from Danilova et al., 2018
il6 standard conditions Fig. 3 from Danilova et al., 2018
irf3 standard conditions Fig. 1 from Danilova et al., 2018
irf7 standard conditions Fig. 1 from Danilova et al., 2018
isg15 standard conditions Fig. 1 from Danilova et al., 2018
junba standard conditions Fig. 5 from Danilova et al., 2011
kdrl standard conditions Fig. 2 from Danilova et al., 2011
mmp9 standard conditions Fig. 3 from Danilova et al., 2018
mmp13a standard conditions Fig. 3 from Danilova et al., 2018
mpx standard conditions Fig. 2 from Danilova et al., 2011
myb standard conditions Fig. 2 from Danilova et al., 2011
mybbp1a standard conditions Fig. 3 from Chakraborty et al., 2017
myca standard conditions Fig. 3 from Chakraborty et al., 2017
Fig. 5 from Danilova et al., 2011
mycb standard conditions Fig. 3 from Chakraborty et al., 2017
mych standard conditions Fig. 3 from Chakraborty et al., 2017
mycn standard conditions Fig. 3 from Chakraborty et al., 2017
ncl standard conditions Fig. 3 from Chakraborty et al., 2017
npm1a standard conditions Fig. 3 from Chakraborty et al., 2017
pes standard conditions Fig. 3 from Chakraborty et al., 2017
pfkma standard conditions Fig. 4 from Danilova et al., 2011
pklr standard conditions Fig. 4 from Danilova et al., 2011
rag1 standard conditions Fig. 2 from Danilova et al., 2011
rpl11 standard conditions Fig. 1 from Danilova et al., 2011
rrs1 standard conditions Fig. 3 from Chakraborty et al., 2017
runx1 standard conditions Fig. 2Fig. 3Fig. 6 from Danilova et al., 2011
chemical treatment: drug Fig. 6 from Danilova et al., 2011
socs3a standard conditions Fig. 1 from Danilova et al., 2018
socs3b standard conditions Fig. 1 from Danilova et al., 2018
stat1b standard conditions Fig. 1 from Danilova et al., 2018
stat3 standard conditions Fig. 1 from Danilova et al., 2018
Fig. 5 from Danilova et al., 2011
tlr3 standard conditions Fig. 2 from Danilova et al., 2018
tnfa standard conditions Fig. 3 from Danilova et al., 2018
tnfrsf1a standard conditions Fig. 3 from Danilova et al., 2018
tp53 standard conditions Fig. 3Fig. 6 from Danilova et al., 2011
chemical treatment: drug Fig. 6 from Danilova et al., 2011
tp63 standard conditions Fig. 3 from Danilova et al., 2011
tp73 standard conditions Fig. 3 from Danilova et al., 2011
wdr3 standard conditions Fig. 3 from Chakraborty et al., 2017
wdr12 standard conditions Fig. 3 from Chakraborty et al., 2017
Reporter gene expression No data available
PHENOTYPE
Phenotype in rpl11hi3820bTg/hi3820bTg
Phenotype Conditions Figures
blood circulation process quality, normal standard conditions Fig. 1 from Chakraborty et al., 2017
blood vasculature morphology, normal standard conditions Fig. 2 from Danilova et al., 2011
brain apoptotic, abnormal standard conditions text only from Danilova et al., 2011
brain structure, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
cell aging decreased magnitude, abnormal standard conditions Fig. S4 with image from Kishi et al., 2008
cell population proliferation decreased occurrence, abnormal standard conditions Fig. 2 from Danilova et al., 2011
central nervous system necrotic, abnormal standard conditions text only from Amsterdam et al., 2004
common cardinal vein circulating cell decreased amount, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
erythroid lineage cell absent, abnormal standard conditions Fig. 5 from Ear et al., 2015
erythroid lineage cell increased size, abnormal standard conditions Fig. 2 from Danilova et al., 2011
extension decreased thickness, abnormal standard conditions text only from Amsterdam et al., 2004
eye decreased size, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
Fig. S3 with image from Heijnen et al., 2014
Fig. 2 from Danilova et al., 2011
text only from Amsterdam et al., 2004
eye myca expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
eye mycb expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
gut absent, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
gut hypoplastic, abnormal standard conditions text only from Amsterdam et al., 2004
gut immature, abnormal standard conditions Fig. 2 from Danilova et al., 2011
head decreased size, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
Fig. S3 with image from Heijnen et al., 2014
Fig. 2 from Danilova et al., 2011
text only from Amsterdam et al., 2004
head mycb expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
head myca expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
heart edematous, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
intermediate cell mass of mesoderm hematopoietic multipotent progenitor cell decreased amount, abnormal standard conditions Fig. 2Fig. 3 from Danilova et al., 2011
liver absent, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
liver hypoplastic, abnormal standard conditions text only from Amsterdam et al., 2004
liver immature, abnormal standard conditions Fig. 2 from Danilova et al., 2011
mouth absent, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
nucleate erythrocyte decreased amount, abnormal standard conditions Fig. 1Fig. 2 from Chakraborty et al., 2017
Fig. 2Fig. 3 from Danilova et al., 2011
nucleate erythrocyte maturation disrupted, abnormal standard conditions text only from Danilova et al., 2011
pericardium edematous, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
text only from Amsterdam et al., 2004
protein kinase B signaling decreased occurrence, abnormal control Fig. 5 with image from Heijnen et al., 2014
regulation of glucose metabolic process disrupted, abnormal standard conditions Fig. 4 from Danilova et al., 2011
regulation of transcription, DNA-templated disrupted, abnormal standard conditions Fig. 5 from Danilova et al., 2011
ribosomal protein S6 kinase activity increased occurrence, abnormal control Fig. 4 with image from Heijnen et al., 2014
whole organism dead, abnormal chemical treatment: Trolox Fig. S3 with image from Heijnen et al., 2014
whole organism dead, abnormal chemical treatment: Trolox Fig. 7 with image from Heijnen et al., 2014
whole organism dead, abnormal standard conditions text only from Chakraborty et al., 2017
text only from Danilova et al., 2011
whole organism decreased length, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
whole organism decreased life span, abnormal standard conditions text only from Chakraborty et al., 2017
whole organism decreased pigmentation, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
whole organism ncl expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism socs3a expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism il6 expression increased amount, abnormal standard conditions Fig. 3 from Danilova et al., 2018
whole organism npm1a expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism isg15 expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism gnl3 expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism stat1b expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism ifih1 expression increased amount, abnormal standard conditions Fig. 2 from Danilova et al., 2018
whole organism mych expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism irf7 expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism cfb expression increased amount, abnormal standard conditions Fig. 5 from Danilova et al., 2018
whole organism bop1 expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism tlr3 expression increased amount, abnormal standard conditions Fig. 2 from Danilova et al., 2018
whole organism stat3 expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism rrs1 expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism c6 expression increased amount, abnormal standard conditions Fig. 5 from Danilova et al., 2018
whole organism tnfa expression increased amount, abnormal standard conditions Fig. 3 from Danilova et al., 2018
whole organism mmp13a expression increased amount, abnormal standard conditions Fig. 3 from Danilova et al., 2018
whole organism mmp9 expression increased amount, abnormal standard conditions Fig. 3 from Danilova et al., 2018
whole organism mycb expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism socs3b expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism mybbp1a expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism tnfrsf1a expression increased amount, abnormal standard conditions Fig. 3 from Danilova et al., 2018
whole organism mycn expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism pes expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism myca expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism wdr12 expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism wdr3 expression increased amount, abnormal standard conditions Fig. 3 from Chakraborty et al., 2017
whole organism irf3 expression increased amount, abnormal standard conditions Fig. 1 from Danilova et al., 2018
whole organism viable, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
whole organism polysome decreased amount, abnormal standard conditions Fig. 1 from Chakraborty et al., 2017
yolk circular, abnormal standard conditions text only from Amsterdam et al., 2004
yolk grey, abnormal standard conditions text only from Amsterdam et al., 2004

CITATIONS  (9)